Company: CERO
Filing Date: 2025-02-07
Form Type: 424B3
Source: 0001213900-25-011071
Chunk: 319

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-02-07
Form: 424B3
Chunk 319
---
 Stockholders’ 
 Deficit       |             |   |
|:-----------------------------------|:----|:----------------|----------:|:----|:-------|----------:|:----|:-------|-----------:|:----|:-------|-----------:|:----|:-------|------:|:----|:-------|--:|:----|:-----------|----------:|:----|:------------|:------------|:--|:----|:--------------|------------:|:--|
| Balance                            
 at December 31, 2023 (Predecessor) |     |                 | 5,155,703 |     | $      | 4,077,560 |     |        | 22,764,764 |     | $      | 38,023,784 |     |        | 5,845 |     | $      | 1 |     | $          | 1,032,125 |     | $           | (43,089,821 | ) |     | $             | (42,057,695 | ) |
| Stock                              
 based compensation expense         |     |                 |         - |     |        |         - |     |        |          - |     |        |          - |     |        |     - |     |        | - |     |            |     4,431 |     |             | -           |   |     |               |       4,431 |   |
| Net loss                           |     |                 |         - |     |        |         - |     |        |          - |     |        |          - |     |        |     - |     |        | - |     |            |         - |     |             | (572,211    | ) |     |               |    (572,211 | ) |
| Balance                            
 at February 13, 2024 (Predecessor) |     |                 | 5,155,703 |     | $      | 4,077,560 |     |        | 22,764,764 |     | $      | 38,023,784 |     |        | 5,845 |     | $      | 1 |     | $          | 1,036,556 |     | $           | (43,662,032 | ) |     | $             | (42,625,475 | ) |

<div align='center'>F-4</div>

|